Literature DB >> 20974723

Meloxicam-induced enteropathy of the small bowel.

Chaitanya Are1, Mohit Turagam, John A Aucar, Eugene Greenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20974723      PMCID： PMC3060187          DOI： 10.1503/cmaj.091748

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  10 in total

Review 1.  Present status and strategy of NSAIDs-induced small bowel injury.

Authors:  Kazuhide Higuchi; Eiji Umegaki; Toshio Watanabe; Yukiko Yoda; Eijiro Morita; Mitsuyuki Murano; Satoshi Tokioka; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2009-07-01       Impact factor: 7.527

2.  COX-2 inhibition with rofecoxib does not increase intestinal permeability in healthy subjects: a double blind crossover study comparing rofecoxib with placebo and indomethacin.

Authors:  G Sigthorsson; R Crane; T Simon; M Hoover; H Quan; J Bolognese; I Bjarnason
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

3.  Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study.

Authors:  Yasumasa Niwa; Masanao Nakamura; Naoki Ohmiya; Osamu Maeda; Takafumi Ando; Akihiro Itoh; Yoshiki Hirooka; Hidemi Goto
Journal:  J Gastroenterol       Date:  2008-05-06       Impact factor: 7.527

Review 4.  Intestinal permeability in the pathogenesis of NSAID-induced enteropathy.

Authors:  Ingvar Bjarnason; Ken Takeuchi
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

Review 5.  Nonsteroidal anti-inflammatory drugs and lower gastrointestinal complications.

Authors:  Angel Lanas; Federico Sopeña
Journal:  Gastroenterol Clin North Am       Date:  2009-06       Impact factor: 3.806

6.  Characteristics of small bowel injury in symptomatic chronic low-dose aspirin users: the experience of two medical centers in capsule endoscopy.

Authors:  Hiroki Endo; Kunihiro Hosono; Masahiko Inamori; Yuichi Nozaki; Kyoko Yoneda; Koji Fujita; Hirokazu Takahashi; Masato Yoneda; Yasunobu Abe; Hiroyuki Kirikoshi; Noritoshi Kobayashi; Kensuke Kubota; Satoru Saito; Tomohiko Ohya; Kantaro Hisatomi; Takuma Teratani; Nobuyuki Matsuhashi; Atsushi Nakajima
Journal:  J Gastroenterol       Date:  2009-04-17       Impact factor: 7.527

7.  Metronidazole reduces intestinal inflammation and blood loss in non-steroidal anti-inflammatory drug induced enteropathy.

Authors:  I Bjarnason; J Hayllar; P Smethurst; A Price; M J Gumpel
Journal:  Gut       Date:  1992-09       Impact factor: 23.059

8.  Effects of metronidazole and misoprostol on indomethacin-induced changes in intestinal permeability.

Authors:  G R Davies; M E Wilkie; D S Rampton
Journal:  Dig Dis Sci       Date:  1993-03       Impact factor: 3.199

9.  Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study.

Authors:  Laurence Maiden; Bjarni Thjodleifsson; Anna Seigal; Ingvar Iain Bjarnason; David Scott; Sigurbjorn Birgisson; Ingvar Bjarnason
Journal:  Clin Gastroenterol Hepatol       Date:  2007-07-10       Impact factor: 11.382

Review 10.  Small bowel enteroscopy: territory conquered, future horizons.

Authors:  Carol E Semrad
Journal:  Curr Opin Gastroenterol       Date:  2009-03       Impact factor: 3.287
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.